8:00 PM
Jan 03, 2019
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Suzhou Connect raises $55M series B, plans Phase Ib of dermatitis candidate

Suzhou Connect Biopharmaceuticals Ltd. (Taicang, China) raised $55 million on Jan. 2 in a series B round led by new investor Advantech Capital and announced plans to start a Phase...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >